Two top Louisiana officials who are physicians are encouraging residents to get vaccinated against measles as an outbreak ...

Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps ...

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in ...

Q4 2024 Earnings Call Transcript February 26, 2025 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is ...

Viral infections are a predominant cause of liver disease around the world, impacting millions with conditions ranging from mild inflammation to severe ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers at the University of Liverpool and Liverpool School of Tropical Medicine conducted ...

Richard Warwick, Gary Webster, Steve Nicholls and Adrian Goodyear all attended the Lord Mayor Treloar School and College in Hampshire.

Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 –– Biomarker ...

To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...